Diversity combining - Revision history

192.176.1.81: corrected typo: selection combining -> switched combining

2015-01-09T12:16:53Z

corrected typo: selection combining -> switched combining

← Older revision		Revision as of 14:16, 9 January 2015
Line 1:		Line 1:
	~~[[Image:Allostery.png\|thumb\|300px\|right\|An allosteric transition of a protein between R~~ and ~~T states, stabilised by an Agonist, and Inhibitor and a Substrate~~.]]		I am Oscar and I completely dig that name. Managing people is what I do and the salary has been really fulfilling. North Dakota is where me and my husband live. The preferred hobby for my kids and me is to perform baseball and I'm trying to make it a profession.<br><br>Have a look at my web blog at home std test - [http://203.250.78.160/zbxe/?document_srl=817810&mid=gallery your input here] -
	In [[biochemistry]], the '''MWC model''' ('''Monod-Wyman-Changeux model''', also known as the '''concerted model''' or '''symmetry model''') describes [[allosteric]] transitions of proteins made up of identical subunits. It was proposed by [[Jean-Pierre Changeux]] based on his PhD experiments, and ~~described by [[Jacques Monod]], Jeffries Wyman, and [[Jean-Pierre Changeux]]. It stands in opposition to~~ the ~~[[sequential model]]~~.

	~~The concept of two distinct symmetric states~~ is ~~the central postulate of the MWC model.The main idea of the model is that regulated [[protein]]s, such as many [[enzyme]]s~~ and ~~[[Receptor (biochemistry)\|receptor]]s, exist in different interconvertible states ''in the absence of any regulator''~~. The ~~ratio of the different [[chemical conformation\|conformational]] states is determined by thermal [[chemical equilibrium\|equilibrium]]. This~~
	~~model, alternatively termed the MWC model, is defined by~~
	~~the following rules:~~
	~~1. An allosteric protein is an oligomer of protomers~~
	~~that are symmetrically related (for hemoglobin, we shall~~
	~~assume,~~ for ~~the sake of algebraic simplicity, that all four~~
	~~subunits are functionally identical).~~
	~~2. Each protomer can exist in (at least) two conformational~~
	~~states, designated T~~ and ~~R; these states are in equilibrium~~
	~~whether or not ligand is bound to the oligomer.~~
	~~3. The ligand can bind to a protomer in either conformation.~~
	~~Only the conformational change alters the affinity~~
	of a protomer for the ligand. The regulators merely shift the equilibrium toward one state or another. For instance, an [[agonist]] will stabilize the active form of a pharmacological [[receptor (biochemistry)\|receptor]]. Phenomenologically, it looks as if the agonist ''provokes'' the conformational transition. One crucial feature of the model is ~~the dissociation between the binding function (the fraction of protein bound~~ to ~~the regulator),~~ and ~~the state function (the fraction of protein under the activated state), cf below. In the models said of "induced-fit", those functions are identical.~~

	~~In the historical model, each allosteric unit, called a [[protomer]] (generally assumed to be a subunit), can exist in two different conformational states - designated~~ 'R' (for relaxed) or 'T' (for tense) states. In any one molecule, all protomers must be in the same state. That is to say, all subunits must be in either the R or the T state. Proteins with subunits in different states are not allowed by this model. The R state has a higher affinity for the ligand than the T state. Because of that, although the ligand may bind to ~~the subunit when~~ it ~~is in either state, the binding of~~ a ~~ligand will increase the equilibrium in favor of the R state~~.

	~~Two equations can be derived, that express the fractional occupancy of the ligand binding site (Y) and the fraction of the proteins in the R state (R):~~

	~~<math>\bar{Y} = \frac{Lc\alpha(1+c \alpha)^{n-1}+\alpha(1+\alpha)^{n-1}}{(1+\alpha)^n+L(1+c\alpha)^n}~~<~~/math~~>

	<~~math~~>~~\bar{R} = \frac{(1+\alpha)^n}{(1+\alpha)^n+L(1+c\alpha)^n}</math>~~

	~~Where <math>L =~~ [T]_0/[R]_0</math> is the allosteric constant, that is the ratio of proteins in the T and R states in the absence of ligand, <math>c=K_R/K_T</math> is the ratio of the affinities of R and T states for the ligand, and <math>\alpha=[X]/~~K_R<~~/~~math>, the normalised concentration of ligand~~.

	This model explains [[Sigmoid_function\|sigmoidal]] binding properties as change in concentration of ligand over a small range will lead to a vast increase in the proportion of molecules in the R state, and thus will lead to a high association of the ligand to the protein.

	~~The MWC model proved very popular in [[enzymology]], and [[pharmacology]], although it has been shown inappropriate in a certain number of cases~~. The best example of a successful application of the model is the regulation of [[hemoglobin]] function. Extension of the model have been proposed for lattices of proteins, for instance by Changeux, Thiery, Tung and Kittel, by Wyman or by Duke, Le Novere and Bray.

	==~~References ==~~

	*Changeux J.-P. (1964). Allosteric interactions interpreted in terms of quaternary structure. Brookhaven Symposia in Biology, 17: 232-249.
	*Monod J., Wyman J., and Changeux J.-P. (1965). On the nature of allosteric transitions: a plausible model. [[Journal of Molecular Biology\|J. Mol. Biol.]~~] 12: 88-118.~~
	*Changeux J.-P., Thiery J., Tung Y., Kittel C. (1967). On the cooperativity of biological membranes. [[PNAS]] 57: 335-~~341~~
	*Wyman J (1969). Possible allosteric effects in extended biological systems. [[Journal of Molecular Biology\|J. Mol Biol.]] 14:523-538.
	*Edelstein SJ (1971). Extensions of the allosteric model for haemoglobin. [[Nature (journal)\|Nature]]. 230:224-227.
	*Changeux JP, Edelstein SJ (1998). Allosteric receptors after 30 years. [[Neuron (journal)\|Neuron]] 21: 959-980.
	*Duke TA, Le Novere N, Bray D (2001). Conformational spread in a ring of proteins: a stochastic approach to allostery. [[Journal of Molecular Biology\|J. Mol Biol.]] 308:541-553.
	*Changeux JP, Edelstein SJ. (2005) Allosteric mechanisms of signal transduction. [[Science (journal)\|Science]], 2005 Jun 3;308(5727):1424-8.
	~~[[Category:Protein structure]]~~

en>Edward: link ambient noise level using Find link

2014-01-08T21:16:43Z

link ambient noise level using Find link

← Older revision		Revision as of 23:16, 8 January 2014
Line 1:		Line 1:
	~~Nice~~ to ~~satisfy you~~, ~~I am Marvella Shryock~~. ~~Hiring~~ is ~~his occupation~~. ~~Body building~~ is 1 of the ~~issues I love most~~. For ~~years he~~'~~s been living~~ in ~~North Dakota and his family loves~~ it.<br><br>~~my site~~: ~~over~~ the ~~counter std test;~~ [~~http~~:~~//Xrambo~~.~~com/blog/192034 mouse click~~ the ~~up coming web site~~],		[[Image:Allostery.png\|thumb\|300px\|right\|An allosteric transition of a protein between R and T states, stabilised by an Agonist, and Inhibitor and a Substrate.]]
			In [[biochemistry]], the '''MWC model''' ('''Monod-Wyman-Changeux model''', also known as the '''concerted model''' or '''symmetry model''') describes [[allosteric]] transitions of proteins made up of identical subunits. It was proposed by [[Jean-Pierre Changeux]] based on his PhD experiments, and described by [[Jacques Monod]], Jeffries Wyman, and [[Jean-Pierre Changeux]]. It stands in opposition to the [[sequential model]].

			The concept of two distinct symmetric states is the central postulate of the MWC model.The main idea of the model is that regulated [[protein]]s, such as many [[enzyme]]s and [[Receptor (biochemistry)\|receptor]]s, exist in different interconvertible states ''in the absence of any regulator''. The ratio of the different [[chemical conformation\|conformational]] states is determined by thermal [[chemical equilibrium\|equilibrium]]. This
			model, alternatively termed the MWC model, is defined by
			the following rules:
			1. An allosteric protein is an oligomer of protomers
			that are symmetrically related (for hemoglobin, we shall
			assume, for the sake of algebraic simplicity, that all four
			subunits are functionally identical).
			2. Each protomer can exist in (at least) two conformational
			states, designated T and R; these states are in equilibrium
			whether or not ligand is bound to the oligomer.
			3. The ligand can bind to a protomer in either conformation.
			Only the conformational change alters the affinity
			of a protomer for the ligand. The regulators merely shift the equilibrium toward one state or another. For instance, an [[agonist]] will stabilize the active form of a pharmacological [[receptor (biochemistry)\|receptor]]. Phenomenologically, it looks as if the agonist ''provokes'' the conformational transition. One crucial feature of the model is the dissociation between the binding function (the fraction of protein bound to the regulator), and the state function (the fraction of protein under the activated state), cf below. In the models said of "induced-fit", those functions are identical.

			In the historical model, each allosteric unit, called a [[protomer]] (generally assumed to be a subunit), can exist in two different conformational states - designated 'R' (for relaxed) or 'T' (for tense) states. In any one molecule, all protomers must be in the same state. That is to say, all subunits must be in either the R or the T state. Proteins with subunits in different states are not allowed by this model. The R state has a higher affinity for the ligand than the T state. Because of that, although the ligand may bind to the subunit when it is in either state, the binding of a ligand will increase the equilibrium in favor of the R state.

			Two equations can be derived, that express the fractional occupancy of the ligand binding site (Y) and the fraction of the proteins in the R state (R):

			<math>\bar{Y} = \frac{Lc\alpha(1+c \alpha)^{n-1}+\alpha(1+\alpha)^{n-1}}{(1+\alpha)^n+L(1+c\alpha)^n}</math>

			<math>\bar{R} = \frac{(1+\alpha)^n}{(1+\alpha)^n+L(1+c\alpha)^n}</math>

			Where <math>L = [T]_0/[R]_0</math> is the allosteric constant, that is the ratio of proteins in the T and R states in the absence of ligand, <math>c=K_R/K_T</math> is the ratio of the affinities of R and T states for the ligand, and <math>\alpha=[X]/K_R</math>, the normalised concentration of ligand.

			This model explains [[Sigmoid_function\|sigmoidal]] binding properties as change in concentration of ligand over a small range will lead to a vast increase in the proportion of molecules in the R state, and thus will lead to a high association of the ligand to the protein.

			The MWC model proved very popular in [[enzymology]], and [[pharmacology]], although it has been shown inappropriate in a certain number of cases. The best example of a successful application of the model is the regulation of [[hemoglobin]] function. Extension of the model have been proposed for lattices of proteins, for instance by Changeux, Thiery, Tung and Kittel, by Wyman or by Duke, Le Novere and Bray.

			==References ==

			*Changeux J.-P. (1964). Allosteric interactions interpreted in terms of quaternary structure. Brookhaven Symposia in Biology, 17: 232-249.
			*Monod J., Wyman J., and Changeux J.-P. (1965). On the nature of allosteric transitions: a plausible model. [[Journal of Molecular Biology\|J. Mol. Biol.]] 12: 88-118.
			*Changeux J.-P., Thiery J., Tung Y., Kittel C. (1967). On the cooperativity of biological membranes. [[PNAS]] 57: 335-341
			*Wyman J (1969). Possible allosteric effects in extended biological systems. [[Journal of Molecular Biology\|J. Mol Biol.]] 14:523-538.
			*Edelstein SJ (1971). Extensions of the allosteric model for haemoglobin. [[Nature (journal)\|Nature]]. 230:224-227.
			*Changeux JP, Edelstein SJ (1998). Allosteric receptors after 30 years. [[Neuron (journal)\|Neuron]] 21: 959-980.
			*Duke TA, Le Novere N, Bray D (2001). Conformational spread in a ring of proteins: a stochastic approach to allostery. [[Journal of Molecular Biology\|J. Mol Biol.]] 308:541-553.
			*Changeux JP, Edelstein SJ. (2005) Allosteric mechanisms of signal transduction. [[Science (journal)\|Science]], 2005 Jun 3;308(5727):1424-8.
			[[Category:Protein structure]]

en>Srleffler: Recat. Adjust a link and remove dup. from See also.

2012-07-14T21:50:48Z

Recat. Adjust a link and remove dup. from See also.

New page

Nice to satisfy you, I am Marvella Shryock. Hiring is his occupation. Body building is 1 of the issues I love most. For years he's been living in North Dakota and his family loves it.<br><br>my site: over the counter std test; [http://Xrambo.com/blog/192034 mouse click the up coming web site],